Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Skye Bioscience, Inc. SKYE

Full chart Compare
Set alert

Price alert · SKYE

All alert types
1.15 USD -0.07 (-5.74%)

Nov 4, 2026, 1:58 PM EST

1.14 Day range 1.30
1.14 52-week range 12.80
YTD
-80.83%
1 year
-89.88%

Financial health

Altman Z-Score

-41.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2016: -1.8×FY 2017: -1.5×FY 2018: -2.7×FY 2019: 16.5×FY 2020: -1.4×FY 2021: -2.6×FY 2022: -0.5×FY 2023: -0.5×FY 2024: -3.9×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.5×
FY 2016: -3.9×FY 2017: -5.7×FY 2018: -3.4×FY 2019: 31.8×FY 2020: 20.5×FY 2021: 3.6×FY 2022: -3.0×FY 2023: -8.9×FY 2024: 1.5×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
P/FCF -0.7×
FY 2016: -1.6×FY 2017: -1.4×FY 2018: -13.3×FY 2019: -2.9×FY 2020: -1.5×FY 2021: -3.2×FY 2022: -0.7×FY 2023: -1.4×FY 2024: -3.8×FY 2025: -0.7×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -0.4×
FY 2016: 0.0×FY 2017: -1.5×FY 2018: -11.1×FY 2019: 7.8×FY 2020: -1.4×FY 2021: -1.9×FY 2022: -0.5×FY 2023: -0.6×FY 2024: -1.4×FY 2025: -0.4×
FY 2016 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -144.8%
FY 2016: -62.3%FY 2017: -72.3%FY 2018: -7.5%FY 2019: -34.6%FY 2020: -65.7%FY 2021: -31.1%FY 2022: -143.8%FY 2023: -73.3%FY 2024: -26.0%FY 2025: -144.8%
FY 2016 5y median -73.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -279.3%
FY 2016: 219.0%FY 2017: 386.7%FY 2018: 123.3%FY 2019: 192.0%FY 2020: -1455.5%FY 2021: -145.3%FY 2022: 647.6%FY 2023: 1765.9%FY 2024: -39.0%FY 2025: -279.3%
FY 2016 5y median -39.0% FY 2025
ROIC -286.6%
FY 2016: 1320.5%FY 2017: 28053.2%FY 2018: 33.6%FY 2019: -645.6%FY 2020: -322.7%FY 2021: -98.1%FY 2022: 1785.6%FY 2023: -1398.7%FY 2024: -44.0%FY 2025: -286.6%
FY 2016 5y median -98.1% FY 2025
ROA -197.5%
FY 2016: -982.8%FY 2017: -555.3%FY 2018: -980.7%FY 2019: 52.7%FY 2020: -245.6%FY 2021: -86.5%FY 2022: -213.8%FY 2023: -315.3%FY 2024: -36.5%FY 2025: -197.5%
FY 2016 5y median -197.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -92.6%
FY 2016: -3.6%FY 2017: 13.7%FY 2018: -21.6%FY 2019: -41.3%FY 2020: 5.2%FY 2021: -24.8%FY 2022: -133.3%FY 2023: -89.7%FY 2024: 13.1%FY 2025: -92.6%
FY 2016 FY 2025
EPS (diluted) -93.2%
FY 2016: 43.7%FY 2017: 35.8%FY 2018: -42.5%FY 2019: 105.4%FY 2020: -476.8%FY 2021: 33.0%FY 2022: -75.4%FY 2023: 38.8%FY 2024: 86.4%FY 2025: -93.2%
FY 2016 FY 2025
Free Cash Flow -60.5%
FY 2016: 4.4%FY 2017: 6.9%FY 2018: -19.0%FY 2019: -52.7%FY 2020: -0.6%FY 2021: -8.3%FY 2022: -94.5%FY 2023: -9.3%FY 2024: -92.2%FY 2025: -60.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.3×
FY 2016: 0.4×FY 2017: 0.7×FY 2018: 0.1×FY 2019: 2.1×FY 2020: 3.4×FY 2021: 2.5×FY 2022: 0.7×FY 2023: 0.8×FY 2024: 16.3×FY 2025: 3.3×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 3.3×
FY 2016: 0.4×FY 2017: 0.7×FY 2018: 0.1×FY 2019: 2.1×FY 2020: 3.4×FY 2021: 2.5×FY 2022: 0.7×FY 2023: 0.8×FY 2024: 16.3×FY 2025: 3.3×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: -0.3×FY 2018: -0.1×FY 2019: 0.7×FY 2020: 3.3×FY 2021: 0.4×FY 2022: -0.7×FY 2023: -2.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: -0.7×FY 2020: 0.2×FY 2021: 0.9×FY 2022: -0.0×FY 2023: -0.1×FY 2024: 2.7×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -5786×FY 2018: -49.5×FY 2019: -6.6×FY 2020: -8.9×FY 2021: -10.2×FY 2022: -27.6×FY 2023: -38.3×FY 2024: -31.2×FY 2025: 0.0×
FY 2016 5y median -27.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31